QQQ   418.82 (+1.01%)
AAPL   165.84 (+0.51%)
MSFT   400.96 (+0.46%)
META   481.73 (+0.14%)
GOOGL   156.28 (+1.42%)
AMZN   177.23 (+1.49%)
TSLA   142.05 (-3.40%)
NVDA   795.18 (+4.35%)
AMD   148.64 (+1.36%)
NIO   4.00 (+5.26%)
BABA   70.68 (+2.33%)
T   16.31 (-1.21%)
F   12.88 (+6.10%)
MU   109.12 (+2.20%)
GE   150.19 (+1.44%)
CGC   7.85 (-1.01%)
DIS   111.99 (-0.55%)
AMC   3.42 (+8.23%)
PFE   26.26 (+1.00%)
PYPL   63.19 (+1.41%)
XOM   120.56 (+0.57%)
QQQ   418.82 (+1.01%)
AAPL   165.84 (+0.51%)
MSFT   400.96 (+0.46%)
META   481.73 (+0.14%)
GOOGL   156.28 (+1.42%)
AMZN   177.23 (+1.49%)
TSLA   142.05 (-3.40%)
NVDA   795.18 (+4.35%)
AMD   148.64 (+1.36%)
NIO   4.00 (+5.26%)
BABA   70.68 (+2.33%)
T   16.31 (-1.21%)
F   12.88 (+6.10%)
MU   109.12 (+2.20%)
GE   150.19 (+1.44%)
CGC   7.85 (-1.01%)
DIS   111.99 (-0.55%)
AMC   3.42 (+8.23%)
PFE   26.26 (+1.00%)
PYPL   63.19 (+1.41%)
XOM   120.56 (+0.57%)
QQQ   418.82 (+1.01%)
AAPL   165.84 (+0.51%)
MSFT   400.96 (+0.46%)
META   481.73 (+0.14%)
GOOGL   156.28 (+1.42%)
AMZN   177.23 (+1.49%)
TSLA   142.05 (-3.40%)
NVDA   795.18 (+4.35%)
AMD   148.64 (+1.36%)
NIO   4.00 (+5.26%)
BABA   70.68 (+2.33%)
T   16.31 (-1.21%)
F   12.88 (+6.10%)
MU   109.12 (+2.20%)
GE   150.19 (+1.44%)
CGC   7.85 (-1.01%)
DIS   111.99 (-0.55%)
AMC   3.42 (+8.23%)
PFE   26.26 (+1.00%)
PYPL   63.19 (+1.41%)
XOM   120.56 (+0.57%)
QQQ   418.82 (+1.01%)
AAPL   165.84 (+0.51%)
MSFT   400.96 (+0.46%)
META   481.73 (+0.14%)
GOOGL   156.28 (+1.42%)
AMZN   177.23 (+1.49%)
TSLA   142.05 (-3.40%)
NVDA   795.18 (+4.35%)
AMD   148.64 (+1.36%)
NIO   4.00 (+5.26%)
BABA   70.68 (+2.33%)
T   16.31 (-1.21%)
F   12.88 (+6.10%)
MU   109.12 (+2.20%)
GE   150.19 (+1.44%)
CGC   7.85 (-1.01%)
DIS   111.99 (-0.55%)
AMC   3.42 (+8.23%)
PFE   26.26 (+1.00%)
PYPL   63.19 (+1.41%)
XOM   120.56 (+0.57%)
TSE:BHC

Bausch Health Companies (BHC) Stock Price, News & Analysis

C$11.58
-0.36 (-3.02%)
(As of 04:25 PM ET)
Today's Range
C$11.54
C$12.10
50-Day Range
C$11.28
C$14.35
52-Week Range
C$7.56
C$15.43
Volume
288,127 shs
Average Volume
359,573 shs
Market Capitalization
C$4.23 billion
P/E Ratio
N/A
Dividend Yield
0.76%
Price Target
C$9.00

Bausch Health Companies MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
22.5% Downside
C$9.00 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.12 out of 5 stars

BHC stock logo

About Bausch Health Companies Stock (TSE:BHC)

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

BHC Stock Price History

BHC Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
BHC Mar 2024 8.500 call
See More Headlines
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/22/2024
Next Earnings (Confirmed)
5/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
20,270
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$9.00
High Stock Price Target
C$9.00
Low Stock Price Target
C$9.00
Potential Upside/Downside
-22.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-592,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8.76 billion
Cash Flow
C$1.49 per share
Book Value
C($2.80) per share

Miscellaneous

Free Float
N/A
Market Cap
C$4.23 billion
Optionable
Not Optionable
Beta
0.83
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Thomas J. Appio (Age 62)
    CEO & Director
    Comp: $3.79M
  • Mr. John S. Barresi (Age 51)
    Senior VP, Controller, Chief Accounting Officer & Interim CFO
    Comp: $1.1M
  • Ms. Seana Carson (Age 51)
    Executive VP & General Counsel
    Comp: $1.2M
  • Mr. Mirza Dautbegovic
    Senior VP & COO
  • Mr. Josh Coyle
    Senior Vice President of Sales & Salix
  • Ms. Kathleen Fitzpatrick
    Senior VP & Chief HR Officer
  • Dr. Tage Ramakrishna M.D. (Age 50)
    Chief Medical Officer and President of R&D
  • Mr. Jeff Hartness
    Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs
  • Dr. Graham Jackson
    Senior VP & Chief Quality Officer
  • Mr. Cees Heiman
    Senior Vice President of Europe & Canada

BHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
View BHC analyst ratings
or view top-rated stocks.

What is Bausch Health Companies' stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for Bausch Health Companies' shares. Their BHC share price targets range from C$9.00 to C$9.00. On average, they predict the company's share price to reach C$9.00 in the next year. This suggests that the stock has a possible downside of 22.5%.
View analysts price targets for BHC
or view top-rated stocks among Wall Street analysts.

How have BHC shares performed in 2024?

Bausch Health Companies' stock was trading at C$10.63 at the beginning of 2024. Since then, BHC shares have increased by 9.3% and is now trading at C$11.62.
View the best growth stocks for 2024 here
.

When is Bausch Health Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our BHC earnings forecast
.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc. (TSE:BHC) announced its quarterly earnings results on Thursday, February, 22nd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.19. The firm had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.05 billion. Bausch Health Companies had a negative net margin of 6.76% and a negative trailing twelve-month return on equity of 686.52%.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), Nutrien (NTR), Suncor Energy (SU) and ARC Resources (ARX).

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:BHC) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners